Restoring Clotting Confidence: CI Perspectives on the Future of Hemophilia B Treatment
The Hemophilia B treatment landscape is entering a new era, marked by disruptive innovation, curative potential, and renewed global attention. Once viewed as a lifelong burden requiring constant infusions and clinical oversight, Hemophilia B is now at the forefront of biopharmaceutical advancement. Driven by gene therapy breakthroughs, next-generation factor IX replacements, and expanding...
0 Комментарии 0 Поделились 15 Просмотры 0 предпросмотр
Спонсоры